A Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
city
~16 mi. (Legnano, Italy, +156 more cities)
facility
Ospedale Civile di Legnano - ASST Ovest Milanese /ID# 222989
biomarker
IGH-CCND1 Fusion, +1 more biomarker
drug
dexamethasone, +1 more drug
drug type
chemotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
city
~17 mi. (Rozzano, Italy, +89 more cities)
facility
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 1114)
biomarker
ER Positive, +2 more biomarkers
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
city
~17 mi. (Rozzano, Italy, +383 more cities)
facility
Istituto Clinico Humanitas
biomarker
ER Negative, +2 more biomarkers
drug
atezolizumab, +4 more drugs
drug type
chemotherapy, +1 more type
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
city
~17 mi. (Rozzano, Italy, +226 more cities)
facility
Istituto Clinico Humanitas Research Hospital ( Site 0452)
drug
enzalutamide, +1 more drug
drug type
hormone therapy, +1 more type
Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer
city
~17 mi. (Rozzano, Italy, +153 more cities)
facility
IRCSS Istituto Clinico Humanitas - U.O. Oncologia Medica
condition
Bladder Urothelial Carcinoma, +2 more conditions
drug
BCG solution, +1 more drug
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
city
~17 mi. (Rozzano, Italy, +158 more cities)
facility
Istituto Clinico Humanitas Research Hospital ( Site 1000)
drug
olaparib, +4 more drugs
drug type
chemotherapy, +3 more types
A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy
city
~17 mi. (Rozzano, Italy, +179 more cities)
facility
Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia
drug
atezolizumab, +1 more drug
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~17 mi. (Rozzano, Italy, +201 more cities)
facility
Istituto Clinico Humanitas /ID# 220815
drug
azacitidine, +1 more drug